TELA Bio (TELA) FCF Margin Growth (5y) (2023 - 2026)
TELA Bio (TELA) FCF Margin Growth (5y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.16 Bn | 176.87 Bn | 6.27 Bn |
| 2 | Stryker | 128.86 Bn | 125.98 Bn | 3.81 Bn |
| 3 | Medtronic | 108.89 Bn | 99.67 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.44 Bn | 43.76 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.16 Bn | 1.98 Bn |
| 7 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn |
| 10 | TELA Bio | 35.02 Mn | -4.52 Mn | 12.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,722.00 |
| Dec 31, 2025 | 9,936.00 |
| Sep 30, 2025 | 4,141.00 |
| Jun 30, 2025 | 14,230.00 |
| Mar 31, 2025 | 14,525.00 |
| Dec 31, 2024 | 10,109.00 |
| Sep 30, 2024 | 8,870.00 |
| Jun 30, 2024 | 9,310.00 |
| Mar 31, 2024 | 14,900.00 |
| Dec 31, 2023 | 17,499.00 |